NO20012849L - Ny terapeutisk anvendelse for hepariner med lav molekylvekt - Google Patents

Ny terapeutisk anvendelse for hepariner med lav molekylvekt

Info

Publication number
NO20012849L
NO20012849L NO20012849A NO20012849A NO20012849L NO 20012849 L NO20012849 L NO 20012849L NO 20012849 A NO20012849 A NO 20012849A NO 20012849 A NO20012849 A NO 20012849A NO 20012849 L NO20012849 L NO 20012849L
Authority
NO
Norway
Prior art keywords
molecular weight
low molecular
new therapeutic
therapeutic application
weight heparins
Prior art date
Application number
NO20012849A
Other languages
English (en)
Other versions
NO20012849D0 (no
Inventor
Andre Uzan
Jean-Marie Stutzmann
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20012849L publication Critical patent/NO20012849L/no
Publication of NO20012849D0 publication Critical patent/NO20012849D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
NO20012849A 1998-12-17 2001-06-08 Ny terapeutisk anvendelse for hepariner med lav molekylvekt NO20012849D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9815919A FR2787329B1 (fr) 1998-12-17 1998-12-17 Nouvelle application therapeutique des heparines de bas poids moleculaire
PCT/FR1999/003109 WO2000035462A1 (fr) 1998-12-17 1999-12-13 Nouvelle application therapeutique des heparines de bas poids moleculaire

Publications (2)

Publication Number Publication Date
NO20012849L true NO20012849L (no) 2001-06-08
NO20012849D0 NO20012849D0 (no) 2001-06-08

Family

ID=9534065

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012849A NO20012849D0 (no) 1998-12-17 2001-06-08 Ny terapeutisk anvendelse for hepariner med lav molekylvekt

Country Status (15)

Country Link
US (4) US20020040013A1 (no)
EP (1) EP1140119B1 (no)
JP (1) JP2002532431A (no)
AT (1) ATE273711T1 (no)
AU (1) AU1569700A (no)
CA (1) CA2354762C (no)
DE (1) DE69919578T2 (no)
DK (1) DK1140119T3 (no)
ES (1) ES2222748T3 (no)
FR (1) FR2787329B1 (no)
IL (2) IL143279A0 (no)
NO (1) NO20012849D0 (no)
PT (1) PT1140119E (no)
SI (1) SI1140119T1 (no)
WO (1) WO2000035462A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
US7511026B2 (en) 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
US20070134260A1 (en) * 2003-03-28 2007-06-14 Georg Feger Use of clusterin for the treatment and/or prevention of peripheral neurological diseases
FR3000746A1 (fr) 2013-01-04 2014-07-11 Centre Nat Rech Scient Peptide pour son utilisation dans le traitement des neuronopathies motrices
RU2639574C2 (ru) * 2016-05-23 2017-12-21 Алексей Георгиевич Александров Способ получения низкомолекулярного гепарина

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
JPH04507234A (ja) * 1988-04-22 1992-12-17 ベイラー・カレッジ・オブ・メディスン 筋萎縮性側索硬化症の治療用組成物の製造方法
EP0493533A4 (en) * 1989-10-27 1992-10-28 Case Western Reserve University Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans
US6258341B1 (en) * 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
US6491965B1 (en) * 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
FR2763849B1 (fr) * 1997-05-28 2000-09-15 Rhone Poulenc Rorer Sa Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux
US6608042B2 (en) * 2000-03-28 2003-08-19 Aventis Pharma, S.A. Pharmaceutical compositions containing oligosaccharides, the novel oligosaccharides and preparation thereof

Also Published As

Publication number Publication date
FR2787329B1 (fr) 2001-02-09
US20030236222A1 (en) 2003-12-25
CA2354762C (fr) 2010-02-09
AU1569700A (en) 2000-07-03
DE69919578D1 (de) 2004-09-23
US20020040013A1 (en) 2002-04-04
DE69919578T2 (de) 2005-07-14
DK1140119T3 (da) 2004-12-20
FR2787329A1 (fr) 2000-06-23
EP1140119A1 (fr) 2001-10-10
US20040038938A1 (en) 2004-02-26
PT1140119E (pt) 2004-11-30
US20060100175A1 (en) 2006-05-11
IL143279A (en) 2006-12-10
ES2222748T3 (es) 2005-02-01
WO2000035462A1 (fr) 2000-06-22
ATE273711T1 (de) 2004-09-15
JP2002532431A (ja) 2002-10-02
IL143279A0 (en) 2002-04-21
EP1140119B1 (fr) 2004-08-18
NO20012849D0 (no) 2001-06-08
SI1140119T1 (en) 2004-10-31
CA2354762A1 (fr) 2000-06-22

Similar Documents

Publication Publication Date Title
DE69927823D1 (de) Hydrogel für die therapeutische behandlung von aneurysmas
FI972793A0 (fi) Nebivololin käyttö antiaterogeenisenä aineena
NO20005884L (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
NO991619L (no) Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper
BRPI0408889A (pt) uso de clusterina para o tratamento e/ou prevenção de doenças neurológicas periféricas
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
DE60026046D1 (de) 5-hydroxysapogenin derivate mit aktivität gegen demenz
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
NO20012849D0 (no) Ny terapeutisk anvendelse for hepariner med lav molekylvekt
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
NO984160L (no) FremgangsmÕte for behandling eller forebyggelse av interstitiell cystitt
DE69814993D1 (de) Quasi-azeotrope Mischungen auf Basis von 1,1,1,3,3,-Pentafluorobutan, Methylene Chloride und Methanol zur Behandlung von festen Oberflächen
NO995539D0 (no) Anvendelse av hepariner med lav molekylvekt for prevensjon og terapi av cerebrale ödemer
PT1133297E (pt) Nova aplicacao terapeutica da 1,6-dimetil-8beta-hidroximetil-10alfa-metoxiergolina
NO995538L (no) Anvendelse av hepariner med lav molekylvekt for prevensjon og terapi av sentralnervesystem-trauma
NO984198L (no) FremgangsmÕte for behandling av aggresjon
DE69822628D1 (de) Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo[2.1.5-cd]indolizin-derivate
FI103753B (fi) Menetelmä väkirehun käsittelemiseksi
HUP9903881A3 (en) Benzenesulfonamide derivatives usable for the prevention and/or treatment of thrombosis, asthma or allergic and use thereof
UA25252A (uk) Хірургічhий спосіб лікуваhhя захворюваhь артерій hижhіх кіhцівок

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application